Apollomics Inc. Warrant (APLMW)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in Apollomics Inc. Warrant, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

Apollomics Inc. Warrant (APLMW) has returned 36.94% so far this year and 78.82% over the past 12 months.

Based on dividend-adjusted daily data since Nov 26, 2021, APLMW's average daily return is +0.94%, while the average monthly return is +4.96%. At this rate, your investment would double in approximately 1.2 years.

Historically, 38% of months were positive and 62% were negative. The best month was Nov 2023 with a return of +200.0%, while the worst month was Aug 2025 at -71.8%. The longest winning streak lasted 3 consecutive months, and the longest losing streak was 4 months.

On a daily basis, APLMW closed higher 30% of trading days. The best single day was Jun 24, 2025 with a return of +114.1%, while the worst single day was Aug 28, 2025 at -58.2%.

Apollomics Inc. Warrant has an annualized alpha of 919.22%, beta of 0.37, and R² of 0.00 versus S&P 500 Index. Calculated based on daily prices since November 29, 2021.

• This stock participated in 196.96% of S&P 500 Index downside but only -63.95% of its upside — more exposed to losses than it benefited from rallies.
• Beta of 0.37 may look defensive, but with R² of 0.00 this stock is largely uncorrelated with S&P 500 Index — low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R² of 0.00 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

APLMW ranks 69 for risk / return — better than 69% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.

The table below present risk-adjusted performance metrics for Apollomics Inc. Warrant (APLMW) and compare them to a chosen benchmark (S&P 500 Index).

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Apollomics Inc. Warrant. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Apollomics Inc. Warrant was 98.77%, occurring on Nov 13, 2024. The portfolio has not yet recovered.

The current Apollomics Inc. Warrant drawdown is 96.77%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Apollomics Inc. Warrant over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Apollomics Inc. Warrant is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.